Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions Ruofei YuanBo WangPinan Liu Review Open access 17 May 2024
Standardizing Integrated Oncology and Palliative Care Across Service Levels: Challenges in Demonstrating Effects in a Prospective Controlled Intervention Trial Anne-Tove BrenneErik Torbjørn LøhreStein Kaasa Original Research Open access 14 May 2024
Some Considerations on the Treatment of Laryngeal Verrucous Squamous Cell Carcinoma Primoz StrojanAlfio Ferlito Editorial Open access 04 May 2024
Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors Eric LoweYael P. Mossé Commentary Open access 27 April 2024
Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example Ronan FoleyJohn Kuruvilla Commentary Open access 25 April 2024
Correction: Real-World Treatment Patterns and Survival Among Patients with Stage I–III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment Soo Jin SeungDaniel MoldaverGeoffrey Liu Correction Open access 16 April 2024
Is There any Relationship Between the Repeated Complications of Sickle Cell Disease and the Potential Development of Acute Leukemia? Giovanna CannasMohamed ElhamriXavier Thomas Commentary Open access 29 March 2024
The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast Fred R. HirschChul Kim Commentary Open access 27 March 2024
Some Considerations on Laryngeal Neuroendocrine Neoplasms Alfio Ferlito Editorial Open access 23 March 2024
Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case Example Kai Hübel Commentary Open access 21 March 2024
The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer Mary K. NeslineVivek SubbiahShakti Ramkissoon Original Research Open access 19 March 2024
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives Luca BertolacciniAndrea De GiglioGiulio Metro Commentary Open access 14 March 2024
Real-World Treatment Patterns and Survival Among Patients with Stage I–III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment Soo Jin SeungDaniel MoldaverGeoffrey Liu Original Research Open access 14 March 2024
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond Carlo BuonerbaConcetta IngenitoGiuseppe Di Lorenzo Editorial Open access 28 February 2024
Epidemiology and Real-World Treatment of Incident Diffuse Large B-cell Lymphoma (DLBCL): A German Claims Data Analysis Scarlette PacisAnna BolzaniChristian Kunz Original Research Open access 20 February 2024
Estimating Public Economic Gains from Early Breast Cancer and Curative Treatment: A Case Study in Human Epidermal Growth Factor Receptor (HER-2) Positive Targeted Therapies Svenn Alexander KommandantvoldNikos KotsopoulosMark P. Connolly Original Research Open access 16 February 2024
Long Term Remission of Capillary Leak Syndrome Associated with Monoclonal Gammopathy with Progression to Multiple Myeloma After Autologous Stem Cell Transplantation: a Case Report and Review of the Literature Gerardo HermidaRodolfo Alvarez-NuñoTomás José González-López Case Report Open access 02 February 2024 Pages: 183 - 188
Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation Xavier Thomas Review Open access 01 February 2024 Pages: 57 - 72
Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies Gere S. diZeregaHolly A. MaulhardtMarc A. Iacobucci Review Open access 30 January 2024 Pages: 31 - 55
Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab Reyes BernabéStephen V. LiuMiriam Alonso García Case Report Open access 27 January 2024 Pages: 175 - 182
Acute Thrombocytopenia Complicating the Initial Administration of Obinutuzumab: Is It More Frequent Than We Think? Umut YılmazSelin KüçükyurtAhmet Emre Eşkazan Case Series Open access 22 January 2024 Pages: 157 - 161
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience Francesco PepeGianluca RussoGiancarlo Troncone Original Research Open access 11 January 2024 Pages: 73 - 95
Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer Giulio MetroEleonora GariazzoGianluigi Lunardi Correction Open access 03 January 2024 Pages: 173 - 174
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario Giuseppe Di LorenzoAieta MicheleCarlo Buonerba Original Research Open access 19 December 2023 Pages: 147 - 155
Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors Hong ChenYan WenNa Xu Original Research Open access 16 December 2023 Pages: 131 - 145
Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia Dany HabrManmohan SinghRoberto Uehara Original Research Open access 08 December 2023 Pages: 115 - 129
Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK Pauline FrankAnne OlshanEmma Sasse Original Research Open access 07 December 2023 Pages: 97 - 114
Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely? Elisa AgostinettoLuca AreccoEvandro de Azambuja Commentary Open access 21 November 2023 Pages: 19 - 29
Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer Giulio MetroEleonora GariazzoGianluigi Lunardi Case Report Open access 16 November 2023 Pages: 163 - 171
Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate? Heidi KoRebecca A. PrevisKamal S. Saini Editorial Open access 14 November 2023 Pages: 13 - 17
From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa Zodwa DlaminiThulo MolefiRodney Hull Editorial Open access 01 November 2023 Pages: 1 - 11
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer Naama HalpernBen BoursiEyal Leshem Brief Report Open access 21 October 2023 Pages: 513 - 519
Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma Javier Sanchez AlvarezMahmoud JaberMarie-Hélène Blanchet Zumofen Original Research Open access 18 October 2023 Pages: 495 - 511
A Meta-analysis of Surgical Outcomes of T4a and Infranotch T4b Oral Cancers Karthik Nagaraja RaoRipudaman AroraAlfio Ferlito Review Open access 07 October 2023 Pages: 461 - 480
Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast Brian DongRita LusenLisa Kline Commentary Open access 29 September 2023 Pages: 411 - 418
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists Stephen V. LiuIvy B. ElkinsSarah B. Goldberg Commentary Open access 26 September 2023 Pages: 419 - 431
The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer Hamdy A. AzimSamah A. LoutfyLoay Kassem Review Open access 20 September 2023 Pages: 445 - 459
Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer Sandhya MehtaJipan XieWinghan J. Kwong Original Research Open access 16 September 2023 Pages: 481 - 493
Recent Advances in Gynecological Malignancies: Focus on ASCO 2023 Olga BodriagovaRebecca Ann PrevisKamal S. Saini Editorial Open access 15 September 2023 Pages: 397 - 409
Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast Reva BashoMegan-Claire Chase Commentary Open access 14 September 2023 Pages: 433 - 443
French Retrospective Database Analysis of Patient Characteristics and Treatment Patterns in Patients with R/R FLT3-Mutated AML: A Registry-Based Cohort Study Andy GarnhamFranck BruonMarie-Hélène Dramard-Goasdoue Original Research Open access 14 August 2023 Pages: 375 - 389
Small-Cell Carcinoma of the Prostate – Challenges of Diagnosis and Treatment: A Next of Kin and Physician Perspective Piece Trish AbbottKenrick NgPaula Muehlschlegel Commentary Open access 25 June 2023 Pages: 291 - 301
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer Kai Conrad Cecil JohnsonDaniel GoldsteinMathew A. Cherian Original Research Open access 24 June 2023 Pages: 361 - 374
Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021 Jessie T. YanYue JinLandon J. Inge Original Research Open access 18 June 2023 Pages: 343 - 360
Neoadjuvant Doxorubicin-Paclitaxel Combined Chemotherapy in Patients with Inoperable Stage III Breast Cancer: A Retrospective Cohort Study with 10 Years of Follow-Up in Vietnam Duc Thanh LeLap Thanh BuiTu Anh Do Original Research Open access 08 June 2023 Pages: 327 - 341
Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast Alex FilicevasThomas Powles Commentary Open access 06 June 2023 Pages: 277 - 289
Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple Myeloma Stephen PalmerYi LinGraham Jackson Original Research Open access 04 June 2023 Pages: 313 - 326
Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth Interviews Todd J. BixbyChristine J. BrittleLisa R. Kallenbach Original Research Open access 21 May 2023 Pages: 303 - 312
Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial Emine Eylem Gençİrem Sena SaraçAhmet Emre Eşkazan Commentary Open access 13 May 2023 Pages: 145 - 152
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma Sundar JagannathNedra JosephAdam D. Cohen Original Research Open access 04 April 2023 Pages: 263 - 275